Latest News and Press Releases

Omni Bridgeway Appoints Peter Galgay as Head of Commercial Strategy and Capital Solutions

SYDNEY, April 01, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces that the first participant has been treated in the open-label extension (OLE) phase of the XanaMIA trial...

DENVER, April 01, 2026 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) is pleased to announce rapid progress on its pilot plant program to...

PERTH, Australia, March 30, 2026 (GLOBE NEWSWIRE) -- Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (Paladin or the Company) has been notified that the Métis Nation–Saskatchewan (MN–S) has...

PERTH, Australien, March 30, 2026 (GLOBE NEWSWIRE) -- Alkane Resources Limited (ASX: ALK, TSX: ALK, OTCQX: ALKRY) (”Alkane”) meddelar att de tecknat en revolverande kredit på 110 miljoner...

IPERIONX – CHANGE OF DIRECTORS AND OFFICERS OWNERSHIP

DENVER, March 30, 2026 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) is pleased to announce that it has engaged Tetra Tech, a U.S. based...

MELBOURNE, Australia and SAN FRANCISCO, March 30, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...

Alkane Executes $110 Million Revolving Credit Facility

On track to share data from first two dose levels in 2H 2026 Targeting KLK3 and leveraging the dual emission of Tb161 represents an innovative approach for radiotherapies in Prostate Cancer ...